$30.60
-3.44-10.11%
Last update: Oct 30, 4:06 PM
Alamar Biosciences Inc
ALMRNASDAQ
Alamar Biosciences (ALMR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Alamar Biosciences (ALMR) last issued guidance on August 10, 2026 for fiscal year 2026. The company guided revenue in the range of $116M - $120M for the period.
| Metric | Q2 '26 | Q1 '26 |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Estimate | $-0.33 | — |
| Actual | $-0.22 | $-1.74 |
| Surprise | +33.3% | — |
| Revenue | ||
| Estimate | $26.0M | — |
| Actual | $29.4M | $26.0M |
| Surprise | +13.4% | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.19 | $-0.19 | $-0.16 | $-0.15 |
| Revenue | ||||
| Consensus | $30.2M | $32.8M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $-0.22 | $-0.33 | 33.3 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $29.43M | $25.96M | 13.4 % |
